Clinical trial
Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI)
NCT01177592 is registered in ClinicalTrials.gov with LifeBridge Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI)
- Lead sponsor
- LifeBridge Health
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 31, 2010
- Completion date
- October 31, 2010
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.